Product Information
IBU-200 200 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0320 per EA under NDC 00904791459. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904791459
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA075139On Market Since
3/1/1999
Pharmacological Classes
Price Statistics
The NADAC for IBU-200 200 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 17.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0320 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0250 (Jul 19, 2017) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0320 |
| Average price | $0.0312 |
| Largest weekly change | -15.1% (Jul 19, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBU-200 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBU-200 200 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0320 per EA (NDC 00904791459), effective Jun 24, 2026.
How has the price of IBU-200 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBU-200 200 MG TABLET has risen 17.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IBU-200 200 MG TABLET?
Since Nov 28, 2013, the NADAC for IBU-200 200 MG TABLET has ranged from a low of $0.0250 (Jul 19, 2017) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0320 per EA.
Are there cheaper alternatives to IBU-200 200 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IBU-200 200 MG TABLET, but none are currently priced below it.
Who manufactures IBU-200 200 MG TABLET?
IBU-200 200 MG TABLET (NDC 00904791459) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification